Delphinidin suppresses ultraviolet B-induced cyclooxygenases-2 expression through inhibition of MAPKK4 and PI-3 kinase

Carcinogenesis

Volumn 30, Issue 11, 2009, Pages 1932-1940

  Kwon, Jung Yeon ^a,b   Lee, Ki Won ^b   Kim, Jong Eun ^a   Jung, Sung Keun ^a,b,c   Kang, Nam Joo ^b,c,d   Hwang, Mun Kyung ^a,b   Heo, Yong Seok ^b   Bode, Ann M ^c   Dong, Zigang ^c   Lee, Hyong Joo ^a  

^a Seoul National University   (South Korea)

^b Konkuk University   (South Korea)

^c UNIVERSITY OF MINNESOTA   (United States)

^d Kyungpook National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; DELPHINIDIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROSTAGLANDIN E2; PROTEIN C JUN; TRANSCRIPTION FACTOR AP 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG PROTEIN BINDING; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EPIDERMIS CELL; FEMALE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; SKIN CANCER; TRANSACTIVATION; ULTRAVIOLET B RADIATION; UPREGULATION;

ANIMALS; ANTHOCYANINS; CELLS, CULTURED; CYCLOOXYGENASE 2; DIETARY CARBOHYDRATES; DINOPROSTONE; ENZYME ACTIVATION; EPIDERMIS; FEMALE; MAP KINASE KINASE 4; MICE; MICE, INBRED ICR; NF-KAPPA B; PHOSPHATIDYLINOSITOL 3-KINASES; SKIN NEOPLASMS; TRANSCRIPTION FACTOR AP-1; ULTRAVIOLET RAYS; UP-REGULATION;

EID: 70849132926     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp216     Document Type: Article

References (41)

1. Balkwill,F. et al. (2001) Inflammation and cancer: Back to Virchow? Lancet, 357, 539-545.
2. Coussens,L.M. et al. (2002) Inflammation and cancer. Nature, 420, 860-867.
3. Higashi,Y. et al. (2000) Enhanced expression of cyclooxygenase (COX)-2 in human skin epidermal cancer cells: Evidence for growth suppression by inhibiting COX-2 expression. Int. J. Cancer, 86 667-671.
4. Lee,J.L. et al. (2003) Cyclooxygenases in the skin: pharmacological and toxicological implications. Toxicol. Appl. Pharmacol., 192, 294-306.
5. Rundhaug,J.E. et al. (2008) Cyclo-oxygenase-2 plays a critical role in UV-induced skin carcinogenesis. Photochem. Photobiol., 84, 322-329.
6. Buckman,S.Y. et al. (1998) COX-2 expression is induced by UVB exposure in human skin: Implications for the development of skin cancer. Carcinogenesis, 19, 723-729.
7. Kang,Y.J. et al. (2006) Cyclooxygenase-2 gene transcription in a macrophage model of inflammation. J. Immunol., 177, 8111-8122.
8. Konstantinopoulos,P.A. et al. (2007) NF-kappaB/PPAR gamma and/or AP-1/PPAR gamma 'on/off' switches and induction of CBP in colon adenocarcinomas: Correlation with COX-2 expression. Int. J. Colorectal Dis., 22, 57-68.
9. Cooper,S.J. et al. (2007) Ultraviolet B regulation of transcription factor families: Roles of nuclear factor-kappa B (NF-kappaB) and activator protein-1 (AP-1) in UVB-induced skin carcinogenesis. Curr. Cancer Drug Targets, 7, 325-334.
10. Bode,A.M. et al. (2003) Mitogen-activated protein kinase activation in UV-induced signal transduction. Sci. STKE, 2003 RE2.
11. Chang,L. et al. (2001) Mammalian MAP kinase signalling cascades. Nature, 410, 37-40.
12. Vivanco,I. et al. (2002) The phosphatidylinositol 3-kinase-AKT pathway in human cancer. Nat. Rev. Cancer, 2, 489-501.
13. Bachelor,M.A. et al. (2005) Inhibition of p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase decreases UVB-induced activator protein-1 and cyclooxygenase-2 in a SKH-1 hairless mouse model. Mol. Cancer Res., 3, 90-99.
14. Tang,Q. et al. (2001) Roles of Akt and glycogen synthase kinase 3beta in the ultraviolet B induction of cyclooxygenase-2 transcription in human keratinocytes. Cancer Res., 61, 4329-4332.
15. Mazza,G. (1995) Anthocyanins in grapes and grape products. Crit. Rev. Food Sci. Nutr., 35, 341-371.
16. Bohm,H. et al. (1998) [Flavonols, flavone and anthocyanins as natural antioxidants of food and their possible role in the prevention of chronic diseases]. Z. Ernahrungswiss., 37, 147-163.
17. Zafra-Stone,S. et al. (2007) Berry anthocyanins as novel antioxidants in human health and disease prevention. Mol. Nutr. Food Res., 51, 675-683.
18. Lamy,S. et al. (2007) Anthocyanidins inhibit migration of glioblastoma cells: Structure-activity relationship and involvement of the plasminolytic system. J. Cell. Biochem., 100, 100-111.
19. Hou,D.X. et al. (2004) Anthocyanidins inhibit activator protein 1 activity and cell transformation: Structure-activity relationship and molecular mechanisms. Carcinogenesis, 25, 29-36.
20. Shih,P.H. et al. (2007) Anthocyanins induce the activation of phase II enzymes through the antioxidant response element pathway against oxidative stress-induced apoptosis. J. Agric. Food Chem., 55, 9427-9435.
21. Choi,E.H. et al. (2007) Cytoprotective effect of anthocyanins against doxorubicin-induced toxicity in H9c2 cardiomyocytes in relation to their anti-oxidant activities. Food Chem. Toxicol., 45, 1873-1881.
22. Zhang,Y. et al. (2005) Human tumor cell growth inhibition by nontoxic anthocyanidins, the pigments in fruits and vegetables. Life Sci., 76, 1465-1472.
23. Chen,P.N. et al. (2006) Black rice anthocyanins inhibit cancer cells invasion via repressions of MMPs and u-PA expression. Chem. Biol. Interact., 163, 218-229.
24. Rice-Evans,C.A. et al. (1996) Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic. Biol. Med., 20, 933-956.
25. Williams,R.J. et al. (2004) Flavonoids: Antioxidants or signalling molecules? Free Radic. Biol. Med., 36, 838-849.
26. Cho,Y.Y. et al. (2007) Ribosomal S6 kinase 2 is a key regulator in tumor promoter-induced cell transformation. Cancer Res., 67, 8104-8112.
27. Kim,J.E. et al. (2009) MKK4 is a novel target for the inhibition of tumor necrosis factor-alpha-induced vascular endothelial growth factor expression by myricetin. Biochem. Pharmacol., 77, 412-421.
28. Lee,K.W. et al. (2008) Raf and MEK protein kinases are direct molecular targets for the chemopreventive effect of quercetin, a major flavonol in red wine. Cancer Res., 68, 946-955.
29. Lee,K.W. et al. (2007) Myricetin is a novel natural inhibitor of neoplastic cell transformation and MEK1. Carcinogenesis, 28, 1918-1927.
30. Dubois,R.N. et al. (1998) Cyclooxygenase in biology and disease. FASEB J., 12, 1063-1073.
31. Prosperi,J.R. et al. (2004) Invasive and angiogenic phenotype of MCF-7 human breast tumor cells expressing human cyclooxygenase-2. Prostaglandins Other Lipid Mediat., 73, 249-264.
32. Ichihashi,M. et al. (2003) UV-induced skin damage. Toxicology 189, 21-39.
33. Tang,X. et al. (2008) Cyclooxygenase-2 inhibitor nimesulide blocks ultra-violet B-induced photocarcinogenesis in SKH-1 hairless mice. Photochem. Photobiol., 84, 522-527.
34. Bol,D.K. et al. (2002) Cyclooxygenase-2 overexpression in the skin of transgenic mice results in suppression of tumor development. Cancer Res., 62, 2516-2521.
35. Fischer,S.M. et al. (2007) Cyclooxygenase-2 expression is critical for chronic UV-induced murine skin carcinogenesis. Mol. Carcinog., 46, 363-371.
36. Whitmarsh,A.J. et al. (2007) Role of mitogen-activated protein kinase kinase 4 in cancer. Oncogene, 26, 3172-3184.
37. Brancho,D. et al. (2003) Mechanism of p38 MAP kinase activation in vivo. Genes Dev., 17, 1969-1978.
38. Walker,E.H. et al. (2000) Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol. Cell, 6, 909-919.
39. Petrelli,A. et al. (2008) From single- to multi-target drugs in cancer therapy: When aspecificity becomes an advantage. Curr. Med. Chem., 15, 422-432.
40. Grandinetti,C.A. et al. (2007) Sorafenib and sunitinib: Novel targeted therapies for renal cell cancer. Pharmacotherapy, 27 1125-1144.
41. Hiles,J.J. et al. (2008) Role of sunitinib and sorafenib in the treatment of metastatic renal cell carcinoma. Am. J. Health Syst. Pharm., 65, 123-131.